The hyper-activation of the PI3K/Akt pathway, caused by mutations of PI3K family genes, determines the poor prognosis in cancers of the brain and of the central nervous system [42,43,44]; the knockdown of the same genes significantly inhibits the invasion of tumours through the hypo-activation of Akt [45]. Here, AKT1 is linked to neoplasm.